Physiological, pharmacological and pathological factors affecting the pharmacokinetics of calcium entry blockers
Padrini, R.; Piovan, D.; Bova, S.; Moretto, R.; Cargnelli, G.; Ferrari, M.
Giornale Italiano di Cardiologia 17(9): 786-790
1987
ISSN/ISBN: 0046-5968 PMID: 3692080 Document Number: 298439
Document emailed within 1 workday
Related Documents
Van Zwieten, P.A. 1985: Calcium antagonists, calcium entry blockers and calcium overload blockers; nomenclature and classification Nederlands Tijdschrift Voor Geneeskunde 129(17): 777-780Horikawa, Y.; Nakajima, H.; Iizuka, K.; Imagawa, A.; Tomita, K.; Shiba, E.; Takai, S.; Miyagawa, J.; Kuwajima, M.; Namba, M.; Hanafusa, T.; Matsuzawa, Y. 1999: In vivo effects of calcium entry blockers on human parathyroid adenoma cells with special reference to calcium sensing ability and the hormone secretion Research Communications in Molecular Pathology and Pharmacology 106(1-2): 87-96
Smith, R.D. 1983: Calcium entry blockers: key issues Federation Proceedings 42(2): 201-206
Vanhoutte, P.M. 1982: Calcium-entry blockers and vascular smooth muscle Circulation 65(1 Part 2): I11-I19
Sole, M.J. 1989: The actions and role of calcium entry blockers in hypertension: cardiac considerations Clinical and Investigative Medicine. Medecine Clinique et Experimentale 12(5): 294-299
Colardyn, F.; Clement, D.L.; Everaert, J. 1988: Peripheral vascular effects of calcium entry blockers in normal volunteers International Angiology: a Journal of the International Union of Angiology 7(3): 258-262
Crawford, M.H. 1989: Theoretical considerations in the use of calcium entry blockers in silent myocardial ischemia Circulation 80(6): Iv74-Iv77
Yoshida, K.; Fujii, Y.; Ina, H.; Fujioka, S.; Maseki, T.; Abe, T. 1990: Effects of cardioplegic solution and calcium entry blockers on coronary artery contraction Nihon Kyobu Geka Gakkai 38(1): 86-92
McGonigle, R.J.; Brookins, J.; Pegram, B.L.; Fisher, J.W. 1987: Enhanced erythropoietin production by calcium entry blockers in rats exposed to hypoxia Journal of Pharmacology and Experimental Therapeutics 241(2): 428-432
Ottaviani, E.; Sassi, D.; Kletsas, D. 1997: PDGF- and TGF-beta-induced changes in cell shape of invertebrate immunocytes: effect of calcium entry blockers European Journal of Cell Biology 74(4): 336-341
Schulte, K.L.; Laber, E.; Meyer-Sabellek, W.A.; Distler, A.; Gotzen, R. 1985: Specific alpha-adrenoceptor-mediated vasoconstriction in human veins and interaction with the calcium entry blockers nifedipine and diltiazem Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S239-S241
Savage, A.O.; Olokodana, N.A. 1988: Differential blockade of potassium and carbachol contractures of toad isolated rectus abdominis muscle by calcium entry blockers, ketamine and hydrallazine Archives Internationales de Pharmacodynamie et de Therapie 291: 175-184
Scott, J. 1981: Physiological, pharmacological and pathological actions of glucocorticoids on the digestive system Clinics in Gastroenterology 10(3): 627-652
Wagner, J.A.; Reynolds, I.J.; Snyder, S.H. 1987: Physiological and pharmacological correlates of calcium antagonist receptors Journal of Cardiovascular Pharmacology 10(Suppl 10): S1-S9
Layer, E.H.; Kennedy, C.E.; Beckham, S.W.; Mbwambo, J.K.; Likindikoki, S.; Davis, W.W.; Kerrigan, D.L.; Brahmbhatt, H. 2014: Multi-level factors affecting entry into and engagement in the HIV continuum of care in Iringa, Tanzania Plos one 9(8): E104961
Layer, P.; Goebell, H. 1989: Calcium homeostasis and exocrine pancreas: physiological ans pathological interrelations Schweizerische Medizinische Wochenschrift 119(47): 1655-1663
Nagata, O.; Murata, M.; Kato, H.; Terasaki, T.; Sato, H.; Tsuji, A. 1990: Physiological pharmacokinetics of a new muscle-relaxant, inaperisone, combined with its pharmacological effect on blood flow rate Drug Metabolism and Disposition: the Biological Fate of Chemicals 18(6): 902-910
Andersen, M.; Jensen, C.H.; Støving, R.K.; Larsen, J.B.; Schrøder, H.D.; Teisner, B.; Hagen, C. 2001: Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels Journal of Clinical Endocrinology and Metabolism 86(11): 5465-5470
Paraskos, J.A. 1986: Cardiovascular pharmacology. III: Atropine, calcium, calcium blockers, and beta-blockers Circulation 74(6 Part 2): Iv86-Iv89
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211